s6y
Company name or ticker
Search
Jasper Therapeutics, Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Friday, April 1, 2022
Accession number
0001213900-22-017515
Documents
PROSPECTUS
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header